(77) reported a 27-year-old female patient with stage IIIB (pT3N2aM0) colorectal cancer characterized as MSI-H/dMMR who developed resistance after two months of anti-PD-1 therapy. This evidence concerns the gene PDCD1 and colorectal cancer.